Genetic Alteration After Systemic Treatment in Breast Cancer
NCT02591966 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2018-01-18
Summary
The purpose of this study is to investigate effects of systemic treatments on genomic profiles in patients with breast cancer and to compare genomic profiling between premenopausal and postmenopausal women by systemic treatments in breast cancer.
Conditions
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2019-12-31
- Completion
- 2020-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Study of Blood Samples in Patients With Breast Cancer
NCT00959556 ·Status: COMPLETED
-
Susceptibility to Breast Cancer
NCT00004565 ·Status: COMPLETED
-
Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients
NCT05901025 ·Status: NOT_YET_RECRUITING
-
ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies
NCT04265937 ·Status: RECRUITING
-
Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer
NCT00590109 ·Status: COMPLETED
-
Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer
NCT05933733 ·Status: RECRUITING
-
Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
NCT06595966 ·Status: RECRUITING
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00897455 ·Status: UNKNOWN
-
Factors Associated With Breast Cancer Risks and Outcomes
NCT07294703 ·Status: RECRUITING
-
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
NCT00897299 ·Status: COMPLETED
-
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
NCT05721326 ·Status: COMPLETED ·Phase: NA
-
T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer
NCT04202328 ·Status: UNKNOWN
-
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
NCT01386411 ·Status: COMPLETED
-
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
NCT00463034 ·Status: UNKNOWN
-
Genetic Studies in Breast Cancer
NCT00582322 ·Status: COMPLETED
-
TME Alteration in HER2 Positive Breast Cancer
NCT06533670 ·Status: ACTIVE_NOT_RECRUITING
-
Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients
NCT00849758 ·Status: COMPLETED
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN
-
Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast Cancer
NCT02557776 ·Status: COMPLETED ·Phase: NA
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
NCT05893966 ·Status: RECRUITING
-
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
NCT00601406 ·Status: UNKNOWN ·Phase: NA
-
Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
NCT05910710 ·Status: RECRUITING